BSI, the business improvement and standards company, has developed a new certification to mitigate the risk of antimicrobial resistance (AMR) in antibiotic manufacturing. The certification, called the Minimized Risk of Antimicrobial Resistance (AMR) certification, will offer independent third-party verification that wastes streams containing antibiotic-active substances are being treated effectively and safely. The certificate is aimed at antibiotic manufacturers worldwide and will help them to demonstrate their commitment to mitigating the risk of AMR and to meet regulatory requirements. The certificate has been developed in collaboration with the AMR Industry Alliance and provides guidance to manufacturers on how to improve waste management programs. The AMR Industry Alliance is the largest life-sciences coalition set up to provide sustainable solutions to curb AMR. The new certificate is an important step towards mitigating the risk of AMR in antibiotic manufacturing and protecting public health.
The certification will offer independent third-party verification that wastes streams containing antibiotic-active substances are being treated effectively and safely.
- The certification is aimed at antibiotic manufacturers worldwide and will help them to demonstrate their commitment to mitigating the risk of AMR and to meet regulatory requirements.
- The certification is an important step towards mitigating the risk of AMR in antibiotic manufacturing and protecting public health.
- The certification scheme will be developed in collaboration with the AMR Industry Alliance and will enable antibiotic manufacturers to further improve their waste management programs.
- The Antibiotic Manufacturing Standard marks the formalization of the Alliance’s 2018 Common Antibiotic Manufacturing Framework, which described a risk-based approach to assessing and controlling antibiotic manufacturing waste streams.
- The certification scheme will be launched in the future, and an independent third party will verify that waste streams containing antibiotic-active substances are being treated effectively and safely.
The new certification is an important step towards mitigating the risk of AMR in antibiotic manufacturing. By ensuring that waste streams containing antibiotic-active substances are being treated effectively and safely, manufacturers can help to reduce the risk of AMR and protect public health. The certification will also help manufacturers to meet regulatory requirements and demonstrate their commitment to mitigating the risk of AMR.
Connect with US
Subscribers to the Morulaa website have access to the most recent and relevant medical news from regulatory bodies like the FDA, TGA, Australia, MHRA, and MDA, among others. Morulaa can assist you with the registration of a medical device in India or other Southeast Asian nations.
Source: BSI New Certification
